U

Synaptiflora

AI-Powered Microbiome Intelligence Suite for Precision Drug Development
Startup Pre-Funding Founded 2024 Health Tech & Life Sciences
Last Update Jul 15, 2025 · Claimed

Synaptiflora Business

Business models
B2B
Product stage
R&D
Employees
1-10

Sector

Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentDigital HealthcareClinical Workflow

Target Customer

Healthcare & Life SciencesLife SciencesPharmaceuticalsBiotechnology

Core Technology

Artificial IntelligenceGenerative AIDeep LearningMachine Learning

Tags (6)

drug-developmentbiopharmaceuticalsaasclinical-trialspharmaceuticalsartificial-intelligence

Geographic Markets

EuropeUnited StatesIsrael